arrow
S

Sandrine Susini

universite paris cite
H指数:13
被引数:530

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1

肿瘤内抗CTLA4联合静脉注射抗PD1的安全性和有效性

Nature
IF48.5
2026-04-290
OAAI
Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers

在原发性人类癌症中,免疫检查点主要由克隆扩增的CD4 FoxP3肿瘤内T细胞共表达

2023-12-062
OAAI
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1+Antiangiogenesis in Malignant Pleural Mesothelioma
2023-01-208
OAAI
Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy?s initial experience with its first 100 patients
2022-09-0111
OAAI
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers
2022-07-0721
OAAI
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer
2022-06-1521
OAAI
BACILLUS CALMETTE-GUERIN CAN SUBVERT PATIENTS ANTITUMOR IMMUNE RESPONSE BY DOWNREGULATING HLA-I EXPRESSION ON CANCER CELLS
2021-11-100
OA
Interventional Radiology for Local Immunotherapy in Oncology
2021-01-0830
OA
Immunodynamics of explanted human tumors for immuno-oncology
2020-12-2910
OAAI
Prospective immune phenotyping of neuroblastoma children at diagnosis reveals specific immune defects related to the aggressiveness of the disease
2019-07-010
PRE